10 20 30 40 50 60 70 80 1S9L - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER RNA 05-FEB-04 1S9L
TITLE NMR SOLUTION STRUCTURE OF A PARALLEL LNA QUADRUPLEX
COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-((TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN))-3'; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS SEQUENCE CONTAINS ALL LNA RESIDUES
KEYWDS LNA, QUADRUPLEX, RNA
EXPDTA SOLUTION NMR
NUMMDL 20
AUTHOR A.RANDAZZO,V.ESPOSITO,O.OHLENSCHLAGER,R.RAMACHANDRAN, AUTHOR 2 L.MAYOLA
REVDAT 2 24-FEB-09 1S9L 1 VERSN REVDAT 1 29-JUN-04 1S9L 0
JRNL AUTH A.RANDAZZO,V.ESPOSITO,O.OHLENSCHLAGER, JRNL AUTH 2 R.RAMACHANDRAN,L.MAYOLA JRNL TITL NMR SOLUTION STRUCTURE OF A PARALLEL LNA JRNL TITL 2 QUADRUPLEX. JRNL REF NUCLEIC ACIDS RES. V. 32 3083 2004 JRNL REFN ISSN 0305-1048 JRNL PMID 15181173 JRNL DOI 10.1093/NAR/GKH629
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER 98 REMARK 3 AUTHORS : ACCELRYS REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 292 (73 PER STRAND) NOE-DERIVED REMARK 3 DISTANCE CONSTRAINTS, 48 HYDROGEN BONDS CONSTRAINTS, 36 (9 PER REMARK 3 STRAND) DIHEDRAL ANGLE RESTRAINTS. THE 20 STRUCTURES WITH THE REMARK 3 LOWEST CYANA TARGET FUNCTIONS WERE SUBJECTED ENERGY REMARK 3 MINIMIZATION (WITH NO ANGLE CONSTRAINTS) USING THE CONJUGATE REMARK 3 GRADIENT METHOD AND THE CVFF FORCE FIELD
REMARK 4 REMARK 4 1S9L COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-04. REMARK 100 THE RCSB ID CODE IS RCSB021539.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.80 MM, 5'-((TLN)P*(LCG)P* REMARK 210 (LCG)P*(LCG)P*(TLN))-3', 10 MM KH2PO4, 70 MM KCL, 0.2 MM EDTA, REMARK 210 H2O/D2O 9:1; 1.80 MM, 5'-((TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN))- REMARK 210 3', 10 MM KH2PO4, 70 MM KCL, 0.2 MM EDTA, D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, 2D TOCSY, 1H-31P 2D REMARK 210 COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ, 750 MHZ, 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX, INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER, VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : UXNMR 970101, VNMR 6.1/C, REMARK 210 FELIX 98, CYANA 1.0.6 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
DBREF 1S9L A 1 5 PDB 1S9L 1S9L 1 5 DBREF 1S9L B 6 10 PDB 1S9L 1S9L 6 10 DBREF 1S9L C 11 15 PDB 1S9L 1S9L 11 15 DBREF 1S9L D 16 20 PDB 1S9L 1S9L 16 20
SEQRES 1 A 5 TLN LCG LCG LCG TLN SEQRES 1 B 5 TLN LCG LCG LCG TLN SEQRES 1 C 5 TLN LCG LCG LCG TLN SEQRES 1 D 5 TLN LCG LCG LCG TLN
MODRES 1S9L TLN A 1 DU MODRES 1S9L LCG A 2 DG MODRES 1S9L LCG A 3 DG MODRES 1S9L LCG A 4 DG MODRES 1S9L TLN A 5 DU MODRES 1S9L TLN B 6 DU MODRES 1S9L LCG B 7 DG MODRES 1S9L LCG B 8 DG MODRES 1S9L LCG B 9 DG MODRES 1S9L TLN B 10 DU MODRES 1S9L TLN C 11 DU MODRES 1S9L LCG C 12 DG MODRES 1S9L LCG C 13 DG MODRES 1S9L LCG C 14 DG MODRES 1S9L TLN C 15 DU MODRES 1S9L TLN D 16 DU MODRES 1S9L LCG D 17 DG MODRES 1S9L LCG D 18 DG MODRES 1S9L LCG D 19 DG MODRES 1S9L TLN D 20 DU
HET TLN A 1 32 HET LCG A 2 35 HET LCG A 3 35 HET LCG A 4 35 HET TLN A 5 35 HET TLN B 6 32 HET LCG B 7 35 HET LCG B 8 35 HET LCG B 9 35 HET TLN B 10 35 HET TLN C 11 32 HET LCG C 12 35 HET LCG C 13 35 HET LCG C 14 35 HET TLN C 15 35 HET TLN D 16 32 HET LCG D 17 35 HET LCG D 18 35 HET LCG D 19 35 HET TLN D 20 35
HETNAM TLN [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- HETNAM 2 TLN DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN HETNAM 3 TLN PHOSPHATE HETNAM LCG [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- HETNAM 2 LCG DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN HETNAM 3 LCG PHOSPHATE
FORMUL 1 TLN 8(C11 H15 N2 O9 P) FORMUL 1 LCG 12(C11 H14 N5 O8 P)
LINK O3' TLN A 1 P LCG A 2 1555 1555 1.62 LINK O3' LCG A 2 P LCG A 3 1555 1555 1.61 LINK O3' LCG A 3 P LCG A 4 1555 1555 1.62 LINK O3' LCG A 4 P TLN A 5 1555 1555 1.62 LINK O3' TLN B 6 P LCG B 7 1555 1555 1.62 LINK O3' LCG B 7 P LCG B 8 1555 1555 1.62 LINK O3' LCG B 8 P LCG B 9 1555 1555 1.62 LINK O3' LCG B 9 P TLN B 10 1555 1555 1.62 LINK O3' TLN C 11 P LCG C 12 1555 1555 1.62 LINK O3' LCG C 12 P LCG C 13 1555 1555 1.62 LINK O3' LCG C 13 P LCG C 14 1555 1555 1.62 LINK O3' LCG C 14 P TLN C 15 1555 1555 1.62 LINK O3' TLN D 16 P LCG D 17 1555 1555 1.62 LINK O3' LCG D 17 P LCG D 18 1555 1555 1.62 LINK O3' LCG D 18 P LCG D 19 1555 1555 1.62 LINK O3' LCG D 19 P TLN D 20 1555 1555 1.62
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000